India
· Delayed Price · Currency is INR Ipca Laboratories Statistics
Total Valuation
NSE:IPCALAB has a market cap or net worth of INR 350.87 billion. The enterprise value is 368.04 billion.
| Market Cap | 350.87B |
| Enterprise Value | 368.04B |
Important Dates
The next estimated earnings date is Tuesday, May 27, 2025.
| Earnings Date | May 27, 2025 |
| Ex-Dividend Date | Nov 27, 2024 |
Share Statistics
NSE:IPCALAB has 253.70 million shares outstanding. The number of shares has increased by 0.05% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 253.70M |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 7.13% |
| Owned by Institutions (%) | 45.31% |
| Float | 139.40M |
Valuation Ratios
The trailing PE ratio is 48.11 and the forward PE ratio is 31.93. NSE:IPCALAB's PEG ratio is 0.85.
| PE Ratio | 48.11 |
| Forward PE | 31.93 |
| PS Ratio | 4.02 |
| PB Ratio | 4.32 |
| P/TBV Ratio | 5.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.85 |
Enterprise Valuation
| EV / Earnings | 50.45 |
| EV / Sales | 4.22 |
| EV / EBITDA | 22.92 |
| EV / EBIT | 30.95 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.75 |
| Debt / FCF | n/a |
| Interest Coverage | 12.97 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.89% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 5.03M |
| Profits Per Employee | 420,796 |
| Employee Count | 17,335 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.39% in the last 52 weeks. The beta is 0.28, so NSE:IPCALAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +3.39% |
| 50-Day Moving Average | 1,396.02 |
| 200-Day Moving Average | 1,469.10 |
| Relative Strength Index (RSI) | 47.36 |
| Average Volume (20 Days) | 304,328 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:IPCALAB had revenue of INR 87.27 billion and earned 7.29 billion in profits. Earnings per share was 28.74.
| Revenue | 87.27B |
| Gross Profit | 56.99B |
| Operating Income | 11.91B |
| Pretax Income | 10.78B |
| Net Income | 7.29B |
| EBITDA | 15.91B |
| EBIT | 11.91B |
| Earnings Per Share (EPS) | 28.74 |
Balance Sheet
The company has 9.03 billion in cash and 12.02 billion in debt, giving a net cash position of -2.99 billion or -11.78 per share.
| Cash & Cash Equivalents | 9.03B |
| Total Debt | 12.02B |
| Net Cash | -2.99B |
| Net Cash Per Share | -11.78 |
| Equity (Book Value) | 81.18B |
| Book Value Per Share | 264.24 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 65.30%, with operating and profit margins of 13.65% and 8.36%.
| Gross Margin | 65.30% |
| Operating Margin | 13.65% |
| Pretax Margin | 12.35% |
| Profit Margin | 8.36% |
| EBITDA Margin | 18.24% |
| EBIT Margin | 13.65% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.29%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 0.29% |
| Dividend Growth (YoY) | 100.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.05% |
| Shareholder Yield | 0.24% |
| Earnings Yield | 2.08% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on January 10, 2022. It was a forward split with a ratio of 2.
| Last Split Date | Jan 10, 2022 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |